Luis A. Díaz

Western University — Canada

Biochemistry, Genetics and Molecular Biology · Life Sciences

125h-index112.7kcitations979works6.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(249), Autoimmune Bullous Skin Diseases(235), Genetic factors in colorectal cancer(178), Coagulation, Bradykinin, Polyphosphates, and Angioedema(141), Urticaria and Related Conditions(122)

Publications977 total

Supplementary Table S2 from The Impact of Germline Alterations in Appendiceal Adenocarcinoma
2025Open Access
Supplementary Figure S1 from The Impact of Germline Alterations in Appendiceal Adenocarcinoma
2025Open Access
Supplementary Table S1 from The Impact of Germline Alterations in Appendiceal Adenocarcinoma
2025Open Access
Supplementary Table S3 from The Impact of Germline Alterations in Appendiceal Adenocarcinoma
2025Open Access
Supplementary Figure S2 from The Impact of Germline Alterations in Appendiceal Adenocarcinoma
2025Open Access
707 Mechanism of MLH1 inactivation predicts benefit to dual immune checkpoint blockade in mismatch repair deficient tumors
Regular and Young Investigator Award Abstracts·2025Open Access
Acquired High Tumor Mutational Burden and Activity of Immunotherapy after Targeted Therapy in Microsatellite Stable Colorectal Cancer
Clinical Cancer Research·2025· 1 citedOpen Access
Impact of Exercise on Clonal Hematopoiesis
JACC Advances·2025Open Access
Abstract B011: Functional interrogation of the pancreatic intratumoral microbial niche reveals tumor modulation and reshaping of the microenvironment
Cancer Research·2025
Maximal Ablative Irradiation Because of Encasement for Patients with Potentially Resectable Locally Advanced Pancreatic Cancer: Final Results of Phase II MAIBE Trial
International Journal of Radiation Oncology*Biology*Physics·2025
Cancer genetics in a tube of blood
Nature Medicine·2025
RARE-seq: an inflection point in cfRNA liquid biopsy
Trends in Pharmacological Sciences·2025
Therapeutic targeting of mismatch repair-deficient cancers
Nature Reviews Clinical Oncology·2025· 8 cited
Clonal hematopoiesis detection by simultaneous assessment of peripheral blood mononuclear cells, blood plasma, and saliva
Journal of Clinical Investigation·2025· 2 citedOpen Access
10-year follow up of a phase 2 clinical trial of pembrolizumab (pembro) in microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) advanced solid tumors.
Journal of Clinical Oncology·2025· 3 cited
Gene-specific outcomes in patients with Lynch syndrome treated by immune checkpoint blockade for advanced cancer.
Journal of Clinical Oncology·2025· 1 cited
Abstract CT002: Circulating tumor DNA status to direct adjuvant immunotherapy for mismatch repair deficient tumors
Cancer Research·2025· 6 cited
Abstract CT003: Non operative management of mismatch repair deficient tumors
Cancer Research·2025
529: GENETIC AND CLINICAL PREDICTORS OF MORTALITY IN STEATOTIC LIVER DISEASE: A PROSPECTIVE COHORT STUDY
Gastroenterology·2025
10: LONGITUDINAL VALIDATION OF THE AGA, AASLD AND EASL CARE PATHWAYS FOR METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN A PROSPECTIVE COHORT OF INDIVIDUALS WITH TYPE 2 DIABETES
Gastroenterology·2025
page 1 of 49Next →

Frequent Co-authors

Bert Vogelstein(29), Kenneth W. Kinzler(27), Nickolas Papadopoulos(18), Victor E. Velculescu(15), Dung T. Le(12), Ralph H. Hruban(7), Laura D. Wood(6), Shibin Zhou(6), Mark Sausen(6), Isaac Kinde(6), Peter Gibbs(6), Bjarne R. Bartlett(5), James R. Eshleman(5), Siân Jones(5), Rebecca Leary(5), Chetan Bettegowda(5), Yuxuan Wang(5), Nishant Agrawal(5), Yuchen Jiao(5), Tian‐Li Wang(5)